Skip to main content
. Author manuscript; available in PMC: 2009 Jun 10.
Published in final edited form as: Gynecol Oncol. 2007 Jul 5;106(3):469–475. doi: 10.1016/j.ygyno.2007.05.008

Table 1.

Patient characteristics

Patient Characteristics (N = 35)

Median Age, y (range) 57 (31- 73)

Stage
 I 2 (6%)
 II 1 (3%)
 III 24 (69%)
 IV 8 (23%)

Histologic Type
 Serous 26 (74%)
 Endometrioid 6 (17%)
 Clear cell 3 (9%)

Size of Residual at Primary Debulking
 Optimal (≤ 1 cm) 16 (46%)
 Suboptimal (> 1 cm) 10 (29%)
 Unknown 9 (26%)

Primary Chemotherapy
 Taxane + platinum 22 (63%)
 Other platinum containing 13 (37%)

Second-line Chemotherapy
 Taxane + platinum 24 (69%)
 Other platinum combination 7 (20%)
 Platinum only 4 (11%)